Virtus Lifesci Biotech Clinical Trials ETF (BBC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BBC | VHT | XBI | ||
| Company | Virtus Lifesci Biotech Clinical Trials ETF | Healthcare ETF Vanguard | S&P Biotech SPDR | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE Arca | NYSE Arca | ||
| Open | 46.10 | 275.61 | 136.14 | ||
| High | 46.13 | 277.12 | 136.63 | ||
| Low | 45.64 | 273.71 | 134.71 | ||
| Latest | 46.08 | 274.15 | 134.94 | ||
| Change | +0.10 | -2.26 | -1.51 | ||
| % Change | +0.21% | -0.82% | -1.11% | ||
| Volume | 9,772 | 113,939 | 4,836,529 | ||
| 20-Day Average Volume | 16,589 | 180,042 | 10,253,325 | ||
| Previous Close | 45.98 | 276.41 | 136.45 | ||
| Industry | N/A | N/A | Finance - Investment Funds | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 42.28 | 272.55 | 127.20 | ||
| 20-Day Raw Stochastic | 98.60% | 64.17% | 86.48% | ||
| 20-Day Relative Strength | 62.97 | 45.69 | 60.75 | ||
| Weighted Alpha | +169.13 | +9.01 | +75.12 | ||
| Today's Opinion | 100% Buy | 8% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 8% Sell | 100% Buy | ||
| Last Month's Opinion | 72% Buy | 24% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.52% since 04/09/26 | -1.27% since 04/09/26 | +2.33% since 04/09/26 | ||
| Low | 43.24 on 04/10/26 | 272.49 on 04/13/26 | 128.76 on 04/10/26 | ||
| High | 46.13 on 04/16/26 | 279.23 on 04/14/26 | 137.50 on 04/15/26 | ||
| 1-Month | |||||
| %Chg | +10.93% since 03/16/26 | -1.74% since 03/16/26 | +8.86% since 03/16/26 | ||
| Low | 38.63 on 03/30/26 | 264.97 on 03/27/26 | 118.19 on 03/24/26 | ||
| High | 46.13 on 04/16/26 | 280.73 on 03/17/26 | 137.50 on 04/15/26 | ||
| 3-Month | |||||
| %Chg | +13.42% since 01/16/26 | -5.38% since 01/16/26 | +8.62% since 01/16/26 | ||
| Low | 38.63 on 03/30/26 | 264.97 on 03/27/26 | 118.19 on 03/24/26 | ||
| High | 46.13 on 04/16/26 | 296.59 on 01/22/26 | 137.50 on 04/15/26 | ||
| 6-Month | |||||
| %Chg | +50.95% since 10/16/25 | +2.99% since 10/16/25 | +25.00% since 10/16/25 | ||
| Low | 28.73 on 11/07/25 | 264.73 on 10/17/25 | 106.30 on 11/07/25 | ||
| High | 46.13 on 04/16/26 | 298.61 on 01/07/26 | 137.50 on 04/15/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 36,784 | 16,440,867 | 8,776,464 | ||
| Shares Outstanding, K | 800 | 59,480 | 64,320 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 0 | 0 | 0 | ||
| Last Quarter Sales | N/A | N/A | N/A | ||
| Last Quarter Net Income | N/A | N/A | N/A | ||
| 60-Month Beta | 0.92 | 0.67 | 0.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | 0.655 on 12/22/25 | 0.994 on 03/24/26 | 0.407 on 12/22/25 | ||
| Next Ex-Dividends Date | 12/22/25 | 03/24/26 | 12/22/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.80 | 18.21 | ||